SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing intense scrutiny and volatility following an earnings report that featured a double-beat but was overshadowed by weak sales outlooks and ongoing struggles in the Chinese market. The community is deeply polarized, with many investors debating whether the stock's multi-year lows represent a generational buying opportunity or evidence of a brand in long-term decline amidst stiff competition and political headwinds.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is trending as market participants debate the stock's massive exposure to Bitcoin and the implications of its ongoing capital-raising strategy, which involves significant share dilution. Community discussions are highly polarized, pitting bulls who view recent price dips as a prime accumulation opportunity against bears who express deep skepticism regarding the firm's debt load and long-term sustainability.

Tema ETF Trust - Tema Space Innovators ETF

Investors are actively debating the potential of the newly launched space-focused ETF, with many drawing comparisons to other high-volatility funds due to its significant exposure to companies like SpaceX. Sentiment is mixed as participants weigh the excitement over the sector's growth potential against questions regarding the fund's underlying structure and liquidity.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing heightened community discussion as investors look toward the company's transition from R&D to production, with participants closely monitoring forward guidance for upcoming unit shipments and revenue. While some stakeholders express frustration over the timing of production milestones and lack of recent order disclosures, others are actively connecting POET's photonics technology to broader AI ecosystem shifts involving major hardware suppliers and hyperscalers.

Ganymede

Ganymede is gaining traction as community members highlight its clean technical structure and consistent accumulation patterns. Investors are actively discussing the potential for significant momentum, viewing the current price action as a disciplined buildup phase.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors focus on the upcoming Phase 3 VELA trial data presentation at the AAD annual meeting, which is expected to reinforce the stock's best-in-class potential for treating hidradenitis suppurativa. Community sentiment remains highly bullish, with active discussions centering on the potential for an imminent buyout and the belief that the stock is significantly undervalued by analysts relative to its long-term scientific merit.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense market focus as investors trade on speculative buyout rumors involving major technology and space players while closely tracking potential catalysts like the upcoming earnings report and regulatory approvals for next-generation satellite constellations. The community remains deeply divided, with some actively connecting dots between recent government contracts and strategic infrastructure partnerships, while others view the stock's lack of consistent volume as a sign of continued volatility in a highly speculative environment.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is currently a major focus for investors as the market anticipates the release of initial commercial sales data for its newly launched drug, Yartemlea. While the community is actively debating the stock's valuation, they are closely monitoring upcoming catalyst events, including potential European regulatory milestones and milestone payments from the ongoing partnership with Novo Nordisk.

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. The firm's products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.

Utah Medical Products, Inc.

Utah Medical Products is currently under investor scrutiny as recent earnings reports reveal a decline in profitability and a squeeze on margins due to OEM weakness and international sales challenges. While some community members highlight the company's debt-free balance sheet and dividend history as signs of resilience, others express concern over customer concentration risks and ongoing legal liabilities.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is experiencing significant upward momentum driven by surging demand for AI-focused data storage, with institutional investors initiating high-conviction bullish ratings. The stock is a focal point of community discussion as traders debate the sustainability of this rally compared to broader semiconductor peers and the structural expansion of the data storage cycle.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TNL Mediagene Leverages AWS's Kiro to Accelerate AI-Enabled Operational Advancements

TNL Mediagene Leverages AWS's Kiro to Accelerate AI-Enabled Operational Advancements TNL Mediagene Leverages AWS's Kiro to Accelerate AI-Enabled Operational Advancements PR Newswire TOKYO, Feb. 24...

TNL Mediagene Announces GIZMART's Debut Project "Keychron Nape Pro" Wins Tom's Hardware's "Best of CES 2026 - Best Mouse" Award

TNL Mediagene Announces GIZMART's Debut Project 'Keychron Nape Pro' Wins Tom's Hardware's 'Best of CES 2026 - Best Mouse' Award TNL Mediagene Announces GIZMART's Debut Project 'Keychron Nape Pro...

TNL Mediagene Targets EBITDA Break-Even in 2026 and Positive EBITDA in 2027Company outlines path driven by technology business growth and cost reductions

TNL Mediagene Targets EBITDA Break-Even in 2026 and Positive EBITDA in 2027Company outlines path driven by technology business growth and cost reductions TNL Mediagene Targets EBITDA Break-Even in...

TNL Mediagene Regains Compliance with Nasdaq's Bid Price Rule

TNL Mediagene Regains Compliance with Nasdaq's Bid Price Rule TNL Mediagene Regains Compliance with Nasdaq's Bid Price Rule PR Newswire TOKYO and TAIPEI, Taiwan, Jan. 22, 2026 TOKYO and TAIPEI...

TNL Mediagene Announces Conclusion of GIZMART's Debut Project "Keychron Nape Pro," Surpassing 300 Million in GMV

TNL Mediagene Announces Conclusion of GIZMART's Debut Project 'Keychron Nape Pro,' Surpassing 300 Million in GMV TNL Mediagene Announces Conclusion of GIZMART's Debut Project 'Keychron Nape Pro...

TNL Mediagene Introduces NLWeb Support to Strengthen Its Digital Media as AI-Native Content Infrastructure for the AI-Driven Web

TNL Mediagene Introduces NLWeb Support to Strengthen Its Digital Media as AI-Native Content Infrastructure for the AI-Driven Web TNL Mediagene Introduces NLWeb Support to Strengthen Its Digital Media...

TNL Mediagene Releases H2 and 2025 Corporate Update Presentation to Shareholders, Highlighting Growth of Technology and Digital Studio Business Units, AI Initiatives, Strategic Partnerships and Content Commerce Initiatives

TNL Mediagene Releases H2 and 2025 Corporate Update Presentation to Shareholders, Highlighting Growth of Technology and Digital Studio Business Units, AI Initiatives, Strategic Partnerships and...

TNL Mediagene Granted Continued Listing by Nasdaq Hearings Panel, Subject to Meeting $1 Bid Price Rule On or Before January 7, 2026

TNL Mediagene Granted Continued Listing by Nasdaq Hearings Panel, Subject to Meeting $1 Bid Price Rule On or Before January 7, 2026 TNL Mediagene Granted Continued Listing by Nasdaq Hearings Panel...

TNL Mediagene to Launch Agentic Newsroom, an AI-Driven Global Content System, and CiteRadar, an SaaS Analytics Platform for Monitoring AI Visibility

TNL Mediagene to Launch Agentic Newsroom, an AI-Driven Global Content System, and CiteRadar, an SaaS Analytics Platform for Monitoring AI Visibility TNL Mediagene to Launch Agentic Newsroom, an...

TNL Mediagene Announces Early Success in AI Content Licensing Revenue Model via TollBit Marketplace Integration and Strategic Partnership

TNL Mediagene Announces Early Success in AI Content Licensing Revenue Model via TollBit Marketplace Integration and Strategic Partnership TNL Mediagene Announces Early Success in AI Content Licensing...

Headquartered in Tokyo, TNL Mediagene was formed in May 2023 through the merger of Taiwan's The News Lens Co. and Japan's Mediagene Inc., two of the region's leading independent digital media groups. The company's operations span original and licensed media brands in Japanese, Chinese, and English, covering topics such as news, business, technology, science, food, sports, and lifestyle. It also offers AI-driven advertising services, marketing technology platforms, e-commerce, and innovative solutions tailored to the needs of advertising agencies. Known for its political neutrality, appeal to younger audiences, and high-quality content, TNL Mediagene has approximately 500 employees across Asia, with offices in Japan, Taiwan, and Hong Kong.

TNL Mediagene.

Sprott Silver Miners & Physical Silver ETF ($SLVR)

Tradr 2x Long Innovation 100 Monthly ($MQQQ)

GraniteShares Autocallable NVDA ETF ($ANV)

Direxion Daily ASML Bull 2x ($ASMU)

The ultimate tool for the active trader. This award goes to the fund that helped traders master the market—whether by protecting against risks or jumping on the latest trends to capture quick wins.

TNMG
TNL Mediagene

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest TNMG News

TNMGTNL Mediagene